Literature DB >> 25189212

Diabetes medications and heart failure: recognizing the risk.

Gregg C Fonarow1.   

Abstract

Entities:  

Keywords:  Editorials; diabetes mellitus; heart failure; hospitalization; treatment outcome

Mesh：

Substances：

Year:  2014        PMID： 25189212     DOI： 10.1161/CIRCULATIONAHA.114.012883

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  8 in total

1.  Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease.

Authors:  Priyesh A Patel; Li Liang; Prateeti Khazanie; Bradley G Hammill; Gregg C Fonarow; Clyde W Yancy; Deepak L Bhatt; Lesley H Curtis; Adrian F Hernandez
Journal:  Circ Heart Fail       Date:  2016-07       Impact factor: 8.790

2.  Omega-3 fatty acid supplementation combined with acute aerobic exercise does not alter the improved post-exercise insulin response in normoglycemic, inactive and overweight men.

Authors:  Eric Rivas; Joshua S Wooten; Daniel E Newmire; Vic Ben-Ezra
Journal:  Eur J Appl Physiol       Date:  2016-05-07       Impact factor: 3.078

3.  Induction of autophagy markers is associated with attenuation of miR-133a in diabetic heart failure patients undergoing mechanical unloading.

Authors:  Shyam Sundar Nandi; Michael J Duryee; Hamid R Shahshahan; Geoffrey M Thiele; Daniel R Anderson; Paras K Mishra
Journal:  Am J Transl Res       Date:  2015-04-15       Impact factor: 4.060

4.  Hospitalisation for heart failure and mortality associated with dipeptidyl peptidase 4 (DPP-4) inhibitor use in an unselected population of subjects with type 2 diabetes: a nested case-control study.

Authors:  Carlo B Giorda; Roberta Picariello; Barbara Tartaglino; Lisa Marafetti; Fabiana Di Noi; Annalisa Alessiato; Giuseppe Costa; Roberto Gnavi
Journal:  BMJ Open       Date:  2015-06-05       Impact factor: 2.692

Review 5.  Diabetes Drugs and Cardiovascular Safety.

Authors:  Ji Cheol Bae
Journal:  Endocrinol Metab (Seoul)       Date:  2016-06-10

Review 6.  Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2.

Authors:  Erin E Mulvihill
Journal:  Curr Opin Lipidol       Date:  2018-04       Impact factor: 4.776

7.  Regulation of cardiac miR-208a, an inducer of obesity, by rapamycin and nebivolol.

Authors:  Rukhsana Gul; Abuzar Mahmood; Christian Luck; Kelly Lum-Naihe; Assim A Alfadda; Robert C Speth; Lakshmi Pulakat
Journal:  Obesity (Silver Spring)       Date:  2015-09-18       Impact factor: 5.002

8.  Dipeptidyl peptidase-4 inhibitors and cardiovascular events in patients with type 2 diabetes, without cardiovascular or renal disease.

Authors:  Sheriza N Baksh; Jodi B Segal; Mara McAdams-DeMarco; Rita R Kalyani; G Caleb Alexander; Stephan Ehrhardt
Journal:  PLoS One       Date:  2020-10-15       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.